AAAAAA
Results:
1-7
|
Results: 7
Authors:
Nikkola, J
Vihinen, P
Vlaykova, T
Hahka-Kemppinen, M
Kahari, VM
Pyrhonen, S
Citation: J. Nikkola et al., High collagenase-1 expression correlates with a favourable chemoimmunotherapy response in human metastatic melanoma, MELANOMA RE, 11(2), 2001, pp. 157-166
Authors:
Gulubova, MV
Vlaykova, T
Citation: Mv. Gulubova et T. Vlaykova, Tenascin immunoreactivity in the large bowel and the liver in patients with colorectal cancer, HISTOCHEM J, 33(2), 2001, pp. 111-120
Authors:
Sauroja, I
Smeds, J
Vlaykova, T
Kumar, R
Talve, L
Hahka-Kemppinen, M
Punnonen, K
Jansen, CT
Hemminki, K
Pyrhonen, S
Citation: I. Sauroja et al., Analysis of G(1)/S checkpoint regulators in metastatic melanoma, GENE CHROM, 28(4), 2000, pp. 404-414
Authors:
Vihinen, P
Nikkola, J
Vlaykova, T
Hahka-Kemppinen, M
Talve, L
Heino, J
Pyrhonen, S
Citation: P. Vihinen et al., Prognostic value of beta 1 integrin expression in metastatic melanoma, MELANOMA RE, 10(3), 2000, pp. 243-251
Authors:
Ilmonen, S
Kariniemi, AL
Vlaykova, T
Muhonen, T
Pyrhonen, S
Asko-Seljavaara, S
Citation: S. Ilmonen et al., Prognostic value of tumour vascularity in primary melanoma, MELANOMA RE, 9(3), 1999, pp. 273-278
Authors:
Vlaykova, T
Laurila, P
Muhonen, T
Hahka-Kemppinen, M
Jekunen, A
Alitalo, K
Pyrhonen, S
Citation: T. Vlaykova et al., Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression, MELANOMA RE, 9(1), 1999, pp. 59-68
Authors:
Vlaykova, T
Talve, L
Hahka-Kemppinen, M
Hernberg, M
Muhonen, T
Franssila, K
Collan, Y
Pyrhonen, S
Citation: T. Vlaykova et al., MIB-1 immunoreactivity correlates with blood vessel density and survival in disseminated malignant melanoma, ONCOL-BASEL, 57(3), 1999, pp. 242-252
Risultati:
1-7
|